v3.21.2
Consolidated Condensed Statements of Cash Flows - USD ($)
$ in Thousands
9 Months Ended
Oct. 02, 2021
Sep. 26, 2020
Cash Flows from Operating Activities:    
Net Loss $ (27,182) $ (95,796)
Adjustments to Reconcile Net Loss to Cash Flows from Operating Activities:    
Depreciation and Amortization 21,950 24,095
Provisions for Non-Cash Losses on Inventory and Receivables 2,750 4,535
Equity-based Compensation Expense 5,147 3,924
Deferred Tax (Benefit) Expense (145) 1,127
Non-cash Severance Expense 182 3,007
Operating Lease Non-Cash Expense 3,783 3,352
Equity Investment Other Than Temporary Impairment 0 3,493
Impairment Loss 0 87,016
Contingent Consideration Liability Fair Value Adjustment (2,200) 0
Other 3,010 6,622
Cash Flows from Changes in Operating Assets and Liabilities:    
Accounts Receivable (15,027) 53,604
Inventories (3,255) (19,807)
Accounts Payable (1,883) (9,589)
Accrued Expenses 1,733 (11,340)
Other Current Assets and Liabilities (666) (224)
Customer Advance Payments and Deferred Revenue (2,215) (6,474)
Income Taxes 217 (12,316)
Operating Lease Liabilities (4,395) (3,412)
Supplemental Retirement and Other Liabilities (304) (304)
Cash Flows from Operating Activities (18,500) 31,513
Cash Flows from Investing Activities:    
Capital Expenditures (4,639) (5,575)
Proceeds on Sale of Assets 30 1,600
Cash Flows from Investing Activities (4,609) (3,975)
Cash Flows from Financing Activities:    
Proceeds from Long-term Debt 20,000 150,000
Payments for Long-term Debt (10,000) (170,000)
Purchase of Outstanding Shares for Treasury 0 (7,732)
Financing Fees 0 (360)
Stock Options Activity 3,187 33
Finance Lease Principal Payments (878) (1,425)
Cash Flows from Financing Activities 12,309 (29,484)
Effect of Exchange Rates on Cash (521) (63)
Decrease in Cash and Cash Equivalents (11,321) (2,009)
Cash and Cash Equivalents at Beginning of Period 40,412 31,906
Cash and Cash Equivalents at End of Period $ 29,091 $ 29,897

Source